Announcements Trials
Browse Landscape

Phase

Phase 2 38Phase 1/2 17Phase 1 14Phase 3 13Phase NA 10Phase 2/3 4Phase EARLY_PHASE1 1

Status

Unknown 1Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Breast 3Other hematologic neoplasm 2Myeloid 2Thoracic 1Other solid neoplasm 1NET 1Gynecologic 1Genitourinary 1Endocrine 1

Conditions

Carcinoma, Hepatocellular 2Rectal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Liver Neoplasms 1Gastroenteropancreatic Neuroendocrine Tumors 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 49Fluorouracil 46Capecitabine 41Cisplatin 36Gemcitabine 29Leucovorin 27Bevacizumab 21Drug Therapy 20Paclitaxel 15Folfox protocol 15Radiotherapy 14Irinotecan 14apatinib 11Neoadjuvant Therapy 11Docetaxel 11sintilimab 9S 1 (combination) 9Trastuzumab 8Sorafenib 8Nivolumab 8Surgical Procedures, Operative 7Magnetic Resonance Spectroscopy 7lenvatinib 6atezolizumab 6XELOX 6Cetuximab 6Albumin-Bound Paclitaxel 6130-nm albumin-bound paclitaxel 6tislelizumab 5pembrolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Injections × Gastrointestinal × Clear all
NCT07165886 2026-04-24

Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 2/3 Recruiting
298 enrolled
EndocrineGastrointestinalNET

Gastroenteropancreatic Neuroendocrine Tumors

NCT07321847 2026-01-07

INJECTABL-3

Immunophotonics, Inc.

Phase 2/3 Not yet recruiting
717 enrolled
Gastrointestinal

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05280444 2022-12-29

Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma

Zhongda Hospital

Phase 2/3 Unknown
216 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00034333 2005-06-24

Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer

FeRx

Phase 2/3 Terminated
240 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡